Literature DB >> 29241144

The diverse reasons for using Novel Psychoactive Substances - A qualitative study of the users' own perspectives.

Christophe Soussan1, Martin Andersson2, Anette Kjellgren3.   

Abstract

BACKGROUND: The increasing number of legally ambiguous and precarious Novel Psychoactive Substances (NPS) constitutes a challenge for policy makers and public health. Scientific and more in-depth knowledge about the motivations for using NPS is scarce and often consist of predetermined, non-systematic, or poorly described reasons deduced from top-down approaches. Therefore, the aim of the present study was to explore and characterize the users' self-reported reasons for NPS use inductively and more comprehensively.
METHODS: The self-reported reasons of a self-selected sample of 613 international NPS users were collected via an online survey promoted at the international drug discussion forum bluelight.org and later analyzed qualitatively using inductive thematic analysis.
RESULTS: The analysis showed that the participants used NPS because these compounds reportedly: 1) enabled safer and more convenient drug use, 2) satisfied a curiosity and interest about the effects, 3) facilitated a novel and exciting adventure, 4) promoted self-exploration and personal growth, 5) functioned as coping agents, 6) enhanced abilities and performance, 7) fostered social bonding and belonging, and 8) acted as a means for recreation and pleasure. The consumption of NPS was also driven by 9) problematic and unintentional use.
CONCLUSION: The present study contributed to a more comprehensive understanding of the users' own and self-reported reasons for using NPS, which needs to be acknowledged not only in order to minimize drug related harm and drug user alienation but also to improve prevention efforts and reduce the potentially counter-intuitive effects of strictly prohibitive policies.
Copyright © 2017 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  drugs; internet; legal highs; motivation; novel psychoactive substances

Mesh:

Substances:

Year:  2017        PMID: 29241144     DOI: 10.1016/j.drugpo.2017.11.003

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  12 in total

1.  Impact of the UK Psychoactive Substances Act on awareness, use, experiences and knowledge of potential associated health risks of novel psychoactive substances.

Authors:  Elena Deligianni; Omari J Daniel; John M Corkery; Fabrizio Schifano; Lisa A Lione
Journal:  Br J Clin Pharmacol       Date:  2020-01-09       Impact factor: 4.335

Review 2.  The e-Psychonauts' 'Spiced' World; Assessment of the Synthetic Cannabinoids' Information Available Online.

Authors:  Caroline Zangani; Fabrizio Schifano; Flavia Napoletano; Davide Arillotta; Liam Gilgar; Amira Guirguis; John M Corkery; Orsola Gambini; Alessandro Vento
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

3.  Awareness of users and motivational factors for using new psychoactive substances in Belgium.

Authors:  Sarah Simonis; Michaël Canfyn; Anton Van Dijck; Tina Van Havere; Eric Deconinck; Peter Blanckaert; Lies Gremeaux
Journal:  Harm Reduct J       Date:  2020-07-25

4.  Twenty percent better with 20 micrograms? A qualitative study of psychedelic microdosing self-rapports and discussions on YouTube.

Authors:  Martin Andersson; Anette Kjellgren
Journal:  Harm Reduct J       Date:  2019-11-28

5.  Toxic Nightlife Relationships, Substance Abuse, and Mental Health: Is There a Link? A Qualitative Case Study of Two Patients.

Authors:  Sandra Racionero-Plaza; Juan Antonio Piñero León; Manuel Morales Iglesias; Leire Ugalde
Journal:  Front Psychiatry       Date:  2021-01-21       Impact factor: 4.157

6.  "Hot" and "Cold" Cognition in Users of Club Drugs/Novel Psychoactive Substances.

Authors:  George Savulich; Owen Bowden-Jones; Robert Stephenson; Annette B Brühl; Karen D Ersche; Trevor W Robbins; Barbara J Sahakian
Journal:  Front Psychiatry       Date:  2021-03-24       Impact factor: 4.157

Review 7.  Abuse of Prescription Drugs in the Context of Novel Psychoactive Substances (NPS): A Systematic Review.

Authors:  Fabrizio Schifano; Stefania Chiappini; John M Corkery; Amira Guirguis
Journal:  Brain Sci       Date:  2018-04-22

8.  Alarming attitudinal barriers to help-seeking in drug-related emergency situations: Results from a Swedish online survey.

Authors:  Christophe Soussan; Anette Kjellgren
Journal:  Nordisk Alkohol Nark       Date:  2019-06-05

9.  Lifetime prevalence of novel psychoactive substances use among adults in the USA: Sociodemographic, mental health and illicit drug use correlates. Evidence from a population-based survey 2007-2014.

Authors:  Jessica Neicun; Justin Christopher Yang; Hueyjong Shih; Pranay Nadella; Robin van Kessel; Attilio Negri; Kasia Czabanowska; Carol Brayne; Andres Roman-Urrestarazu
Journal:  PLoS One       Date:  2020-10-30       Impact factor: 3.240

10.  Beyond the 'purple drank': Study of promethazine abuse according to the European Medicines Agency adverse drug reaction reports.

Authors:  Stefania Chiappini; Fabrizio Schifano; John Martin Corkery; Amira Guirguis
Journal:  J Psychopharmacol       Date:  2021-01-10       Impact factor: 4.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.